Ben Arpad Kappel

Ben Arpad Kappel

Auto-generated profile, based on publicly available information

Ben Arpad Kappel

University Hospital Aachen, RWTH Aachen University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2017 in Circulation
Verified
Journal Article
Closed access
PDF file
BKBen A. Kappel
Ben A. Kappel
MLMichael Lehrke
Michael Lehrke
KSKatharina Schütt
Katharina Schütt
AAAnna Artati
Anna Artati
Jerzy AdamskiJerzy Adamski
Jerzy Adamski
NMNikolaus Marx
Nikolaus Marx

1 June 2020 in Molecular Metabolism
Verified
Journal Article
Open access
BKBen Arpad Kappel
Ben Arpad Kappel
LALorenzo De Angelis
Lorenzo De Angelis
MHMichael Heiser
Michael Heiser
MBMarta Ballanti
Marta Ballanti
RSRobert Stoehr
Robert Stoehr
MFMassimo Federici
Massimo Federici
The metabolic influence of gut microbiota plays a pivotal role in the pathogenesis of cardiometabolic diseases. Antibiotics affect intestinal bacterial diversity, and long-term usage has been identified as an independent risk factor for atherosclerosis-driven events. The aim of this study was to explore the interaction between gut dysbiosis by antibiotics and metabolic pathways with the impact on atherosclerosis development. We combined oral antibiotics with different diets in an Apolipoprotein E-knockout mouse model linking gut microbiota to atherosclerotic lesion development via an integrative cross-omics approach including serum metabolomics and cecal 16S rRNA targeted metagenomic sequencing. We further investigated patients with carotid atherosclerosis compared to control subjects with comparable cardiovascular risk. Here, we show that increased atherosclerosis by antibiotics was connected to a loss of intestinal diversity and alterations of microbial metabolic functional capacity with a major impact on the host serum metabolome. Pathways that were modulated by antibiotics and connected to atherosclerosis included diminished tryptophan and disturbed lipid metabolism. These pathways were related to the reduction of certain members of Bacteroidetes and Clostridia by antibiotics in the gut. Patients with atherosclerosis presented a similar metabolic signature as those induced by antibiotics in our mouse model. Taken together, this work provides insights into the complex interaction between intestinal microbiota and host metabolism. Our data highlight that detrimental effects of antibiotics on the gut flora are connected to a pro-atherogenic metabolic phenotype beyond classical risk factors.

22 March 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
MGMaren Gesper
Maren Gesper
ANAlena B. H. Nonnast
Alena B. H. Nonnast
NKNina Kumowski
Nina Kumowski
RSRobert Stoehr
Robert Stoehr
KSKatharina Schuett
Katharina Schuett
BKBen A. Kappel
Ben A. Kappel
Background: The gut microbiome has been linked to the onset of cardiometabolic diseases, in part facilitated through gut microbiota-dependent metabolites such as trimethylamine-N-oxide. However, molecular pathways associated to heart failure mediated by microbial metabolites remain largely elusive. Mitochondria play a pivotal role in cellular energy metabolism and mitochondrial dysfunction has been associated to heart failure pathogenesis. Aim of the current study was to evaluate the impact of gut-derived metabolites on mitochondrial function in cardiomyocytes via an in vitro screening approach.Methods: Based on a systematic Medline research, 25 microbial metabolites were identified and screened for their metabolic impact with a focus on mitochondrial respiration in HL-1 cardiomyocytes. Oxygen consumption rate in response to different modulators of the respiratory chain were measured by a live-cell metabolic assay platform. For one of the identified metabolites, indole-3-propionic acid, studies on specific mitochondrial complexes, cytochrome c, fatty acid oxidation, mitochondrial membrane potential, and reactive oxygen species production were performed. Mitochondrial function in response to this metabolite was further tested in human hepatic and endothelial cells. Additionally, the effect of indole-3-propionic acid on cardiac function was studied in isolated perfused hearts of C57BL/6J mice.Results: Among the metabolites examined, microbial tryptophan derivative indole-3-propionic acid could be identified as a modulator of mitochondrial function in cardiomyocytes. While acute treatment induced enhancement of maximal mitochondrial respiration (+21.5 ± 7.8%, p < 0.05), chronic exposure led to mitochondrial dysfunction (−18.9 ± 9.1%; p < 0.001) in cardiomyocytes. The latter effect of indole-3-propionic acids could also be observed in human hepatic and endothelial cells. In isolated perfused mouse hearts, indole-3-propionic acid was dose-dependently able to improve cardiac contractility from +26.8 ± 11.6% (p < 0.05) at 1 μM up to +93.6 ± 14.4% (p < 0.001) at 100 μM. Our mechanistic studies on indole-3-propionic acids suggest potential involvement of fatty acid oxidation in HL-1 cardiomyocytes.Conclusion: Our data indicate a direct impact of microbial metabolites on cardiac physiology. Gut-derived metabolite indole-3-propionic acid was identified as mitochondrial modulator in cardiomyocytes and altered cardiac function in an ex vivo mouse model.

22 February 2017 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
PDF file
JMJulia Möllmann
Julia Möllmann
FKFlorian Kahles
Florian Kahles
CLCorinna Lebherz
Corinna Lebherz
BKBen Kappel
Ben Kappel
CBChrister Baeck
Christer Baeck
MLMichael Lehrke
Michael Lehrke

17 March 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RSR. Stöhr
R. Stöhr
MMM. Mavilio
M. Mavilio
AMA. Marino
A. Marino
VCViviana Casagrande
Viviana Casagrande
BKB. Kappel
B. Kappel
MFMassimo Federici
Massimo Federici
Atherosclerosis is a chronic inflammatory disease characterized by the infiltration of pro-inflammatory macrophages into a lipid-laden plaque. ITCH is an E3 ubiquitin ligase that has been shown to polarize macrophages to an anti-inflammatory phenotype. We therefore investigated the effect of ITCH deficiency on the development of atherosclerosis. ApoE−/−ITCH−/− mice fed a western diet for 12 weeks showed increased circulating M2 macrophages together with a reduction in plaque formation. Bone marrow transplantation recreated the haemopoietic phenotype of increased circulating M2 macrophages but failed to affect plaque development. Intriguingly, the loss of ITCH lead to a reduction in circulating cholesterol levels through interference with nuclear SREBP2 clearance. This resulted in increased LDL reuptake through upregulation of LDL receptor expression. Furthermore, ApoE−/−ITCH−/− mice exhibit reduced hepatic steatosis, increased mitochondrial oxidative capacity and an increased reliance on fatty acids as energy source. We found that ITCH ubiquitinates SIRT6, leading to its breakdown and thus promoting hepatic lipid infiltration through reduced fatty acid oxidation. The E3 Ubiquitin Ligase ITCH modulates lipid metabolism impacting on atherosclerosis progression independently from effects on myeloid cells polarization through control of SIRT6 and SREBP2 ubiquitination. Thus, modulation of ITCH may provide a target for the treatment of hypercholesterolemia and hyperlipidemia.

1 June 2016 in Atherosclerosis
Verified
Journal Article
Closed access
BKBen Arpad Kappel
Ben Arpad Kappel
RSRobert Stöhr
Robert Stöhr
LALorenzo De Angelis
Lorenzo De Angelis
MMMaria Mavilio
Maria Mavilio
RMRossella Menghini
Rossella Menghini
MFMassimo Federici
Massimo Federici